References
- Boyle, J. P., Thompson, T. J., Gregg, E. W. et al. (2010) Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence, Population Health Metrics, 8, 29.
- Burnier, M. (2006) Medication adherence and persistence as the cornerstone of effective antihypertensive therapy, American Journal of Hypertension, 19, 1190–6.
- Centers for Disease Control and Prevention (CDC). (2011) National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011, US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA.
- Charlson, M. E., Pompei, P., Ales, K. L. et al. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, Chronic Disease, 40, 373–83.
- Hogan, P., Dall, T. and Nikolov, P. (2003) Economic costs of diabetes in the US in 2002, Diabetes Care, 26, 917–32.
- International Diabetes Federation. (2009) Diabetes Atlas. Available at http://www.diabetesatlas.org/content/regional-overview (accessed 20 October 2013).
- Pi-Sunyer, F. X. (2009) The impact of weight gain on motivation, compliance, and metabolic control in patients with type 2 diabetes mellitus, Postgraduate Medicine, 121, 94–107.
- Stagnitti, M. N., Beauregard, K. and Solis, A. (2008). Design, methods, and field results of the medical expenditure panel survey medical provider component (MEPS MPC) – 2006 calendar year data. Methodology Report No. 23. November 2008. Agency for Healthcare Research and Quality, Rockville, MD. Available at http://www.meps.ahrq.gov/mepsweb/data_files/publications/mr23/mr23.pdf (accessed 20 October 2013).